title: Serious complications associated with regadenoson administration for myocardial perfusion imaging.
authors.affiliation: Astellas Scientific & Medical Affairs, Inc, 1 Astellas Way, Northbrook, IL, 60062, USA, therese.kitt@astellas.com.
authors.forename: Therese
authors.initials: T
authors.lastname: Kitt
authors.forename: Jeanette
authors.initials: J
authors.lastname: Jiang
mesh_terms: D058908:Adenosine A2 Receptor Agonists / Q000009:adverse effects*; D001285:Atropine / Q000627:therapeutic use*; D001919:Bradycardia / Q000139:chemically induced*; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging*; D005080:Exercise Test / Q000009:adverse effects*; D005260:Female; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D008297:Male; D055414:Myocardial Perfusion Imaging / Q000009:adverse effects*; D011687:Purines / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D011720:Pyrazoles / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D014665:Vasodilator Agents / Q000009:adverse effects*
chemical_list: D058908:Adenosine A2 Receptor Agonists; D011687:Purines; D011720:Pyrazoles; D014665:Vasodilator Agents; D001285:Atropine